Strategies to increase central N-acetyl aspartylglutamate: a potential treatment for schizophrenia and bipolar disorders.
Tsai
Shih-Jen
SJ
D001714:Bipolar Disorder / Q000188:drug therapy*; D004151:Dipeptides / Q000627:therapeutic use*; D006801:Humans; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D012559:Schizophrenia / Q000188:drug therapy*
D004151:Dipeptides; D018696:Neuroprotective Agents; C027172:isospaglumic acid